All Resources

Intellectual Property • November 06, 2024

Submission on Global Affairs Canada CUMSA Consultation

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Economic Impact • July 29, 2024

The Canadian Research & Development Pharmaceutical Sector 2021

Learn more | View

July 02, 2024

Submission on Proposed Patent Term Adjustment (PTA) Regulations

Learn more | View

Access to Medicine • June 14, 2024

The Canadian Research and Development Pharmaceutical Sector, 2021

This study examines the contribution of the Canadian research and development (R&D) pharmaceutical sector on the Canadian economy in 2021. It builds on the annual reports produced since 2018, sponsored…

Learn more | View

Pharmacare • June 05, 2024

IMC Open Letter to Senators on Bill C‑64

Learn more | View

Pharmacare • May 23, 2024

IMC Submission to the Standing Committee of Health on Bill C-64

Learn more | View

Economic Impact • January 15, 2024

The Canadian Research & Development Pharmaceutical Sector 2020

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Access to Medicine • October 19, 2023

Cost Drivers Report 2023

Learn more | View

September 08, 2023

Submission on Consultation regarding Patent Term Adjustment (PTA) Regulations

Learn more | View

Access to Medicine • August 21, 2023

IMC Response to the PMPRB’s 2023 Interim Guidance Consultation

Learn more | View